Table 2.
Name | Clonality | Source | Binding | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
C5 | C6 | C7 | C8 | C9 | Poly-C9 | Incomplete C5b-9a | Soluble C5b-9 | Membrane-bound C5b-9 | Ref. | |||
ab55811 | Polyclonal | Rabbit | Unkn. | Unkn. | Unkn. | Unkn. | Unkn. | Unkn. | Unkn. | Unkn. | Unkn. | (53, 54) |
aE11 or M0777 | Monoclonal | Mouse | – | – | – | – | ± | + | + | + | + | (46, 51) |
Anti-C5b-9(m) | Polyclonal | Rabbit | – | – | – | – | – | Unkn. | Unkn. | + | + | (55, 56) |
Anti-MAC | Polyclonal | Rabbit | – | – | – | – | – | Unkn. | Unkn. | + | + | (57) |
Anti-MAC-neo | Polyclonal | Rabbit | – | – | – | – | – | Unkn. | + | + | + | (52) |
bC5 or A239 | Monoclonal | Mouse | – | – | – | – | ± | + | ± | + | + | (46) |
B7 | Monoclonal | Mouse | – | – | – | – | ± | + | Unkn. | + | + | (58, 59) |
Kolb 1975b | Polyclonal | Rabbit | – | – | – | – | – | Unkn. | + | + | + | (50) |
PolyC9-MA | Monoclonal | Mouse | – | – | Unkn. | – | – | + | – | Unkn. | + | (44) |
WU-7,2 | Monoclonal | Mouse | – | – | – | – | ± | – | Unkn. | + | + | (48, 60) |
WU-13,15 | Monoclonal | Mouse | Unkn. | – | – | Unkn. | ± | – | – | + | + | (48, 60) |
X197 | Monoclonal | Mouse | Unkn. | Unkn. | Unkn. | – | + | + | – | Unkn. | + | (47, 49) |
Xia 1988b | Monoclonal | Mouse | – | – | – | – | – | Unkn. | Unkn. | + | + | (61, 62) |
3B1 | Monoclonal | Mouse | – | – | – | – | – | + | – | + | + | (45) |
1B4 | Monoclonal | Unkn. | Unkn. | Unkn. | Unkn. | Unkn. | – | + | Unkn. | + | + | (63) |
All antibodies against C5b-9 used for staining of C5b-9 in the included original studies, as specified per study in Supplementary Table 1 , are indicated. References to studies on their binding selectivity are given.
aIncomplete forms of C5b-9 without C9, either soluble or membrane-bound, commonly referred to as C5b-6, C5b-7, and C5b-8.
bNames used in Supplementary Tables 1 and 2 for antibodies without a specific name.
–, no binding; ±, weak binding; +, strong binding; poly-C9, polymerized C9; unkn., unknown.